Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 50 entries
Sorted by: Best Match Show Resources per page
[Mental disturbances in multiple sclerosis. Pathogentic mechanisms].

Acta neurologica

Gentile A, Florino A, Crispi G, Pannone B, Di Lorenzo R, Sciorio G, Caruso C.
PMID: 1229845
Acta Neurol (Napoli). 1975 Jul-Aug;30(4):404-10.

No abstract available.

Cite
Gentile A, Florino A, Crispi G, et al. I disturbi psichici nella sclerosi multipla. Meccanismi patogenetici [Mental disturbances in multiple sclerosis. Pathogentic mechanisms]. Acta Neurol (Napoli). 1975;30(4):404-10
Gentile, A., Florino, A., Crispi, G., Pannone, B., Di Lorenzo, R., Sciorio, G., & Caruso, C. (1975). I disturbi psichici nella sclerosi multipla. Meccanismi patogenetici [Mental disturbances in multiple sclerosis. Pathogentic mechanisms]. Acta neurologica, 30(4), 404-10.
Gentile, A, et al. "I disturbi psichici nella sclerosi multipla. Meccanismi patogenetici" [Mental disturbances in multiple sclerosis. Pathogentic mechanisms]. Acta neurologica vol. 30,4 (1975): 404-10.
Gentile A, Florino A, Crispi G, Pannone B, Di Lorenzo R, Sciorio G, Caruso C. I disturbi psichici nella sclerosi multipla. Meccanismi patogenetici [Mental disturbances in multiple sclerosis. Pathogentic mechanisms]. Acta Neurol (Napoli). 1975 Jul-Aug;30(4):404-10. Italian. PMID: 1229845.
Copy Download .nbib Format: NLM
Role of MRI in multiple sclerosis I: inflammation and lesions.

Frontiers in bioscience : a journal and virtual library

Zivadinov R, Bakshi R.
PMID: 14766399
Front Biosci. 2004 Jan 01;9:665-83. doi: 10.2741/1251.

Conventional magnetic resonance imaging (MRI) can improve accuracy in the diagnosis of multiple sclerosis (MS). Metrics derived from conventional MRI are now routinely used to detect therapeutic effects and extend clinical observations. Hyperintense lesions on T2-weighted MRI scans are...

Cite
Zivadinov R, Bakshi R. Role of MRI in multiple sclerosis I: inflammation and lesions. Front Biosci. 2004;9:665-83doi: 10.2741/1251.
Zivadinov, R., & Bakshi, R. (2004). Role of MRI in multiple sclerosis I: inflammation and lesions. Frontiers in bioscience : a journal and virtual library, 9665-83. https://doi.org/10.2741/1251
Zivadinov, Robert, and Bakshi, Rohit. "Role of MRI in multiple sclerosis I: inflammation and lesions." Frontiers in bioscience : a journal and virtual library vol. 9 (2004): 665-83. doi: https://doi.org/10.2741/1251
Zivadinov R, Bakshi R. Role of MRI in multiple sclerosis I: inflammation and lesions. Front Biosci. 2004 Jan 01;9:665-83. doi: 10.2741/1251. PMID: 14766399.
Copy Download .nbib Format: NLM
[The mental disorders of multiple sclerosis].

Le Progres medical

ROBERT J.
PMID: 13074248
Prog Med (Paris). 1953 Apr 10;81(7):148-56.

No abstract available.

Cite
ROBERT J. Les troubles mentaux de la sclérose en plaques. [The mental disorders of multiple sclerosis]. Prog Med (Paris). 1953;81(7):148-56
ROBERT, J. (1953). Les troubles mentaux de la sclérose en plaques. [The mental disorders of multiple sclerosis]. Le Progres medical, 81(7), 148-56.
ROBERT, J. "Les troubles mentaux de la sclérose en plaques." [The mental disorders of multiple sclerosis]. Le Progres medical vol. 81,7 (1953): 148-56.
ROBERT J. Les troubles mentaux de la sclérose en plaques. [The mental disorders of multiple sclerosis]. Prog Med (Paris). 1953 Apr 10;81(7):148-56. Undetermined. PMID: 13074248.
Copy Download .nbib Format: NLM
Autonomic dysreflexia in multiple sclerosis.

The journal of spinal cord medicine

Bateman AM, Goldish GD.
PMID: 11939465
J Spinal Cord Med. 2002;25(1):40-2. doi: 10.1080/10790268.2002.11753601.

BACKGROUND: Although autonomic dysreflexia (AD) is well documented in the spinal cord injury (SCI) population, its occurrence in persons with multiple sclerosis (MS) is not. A dense multiple sclerotic lesion in the spinal cord at or above the sixth...

Cite
Bateman AM, Goldish GD. Autonomic dysreflexia in multiple sclerosis. J Spinal Cord Med. 2002;25(1):40-2doi: 10.1080/10790268.2002.11753601.
Bateman, A. M., & Goldish, G. D. (2002). Autonomic dysreflexia in multiple sclerosis. The journal of spinal cord medicine, 25(1), 40-2. https://doi.org/10.1080/10790268.2002.11753601
Bateman, Anne M, and Goldish, Gary D. "Autonomic dysreflexia in multiple sclerosis." The journal of spinal cord medicine vol. 25,1 (2002): 40-2. doi: https://doi.org/10.1080/10790268.2002.11753601
Bateman AM, Goldish GD. Autonomic dysreflexia in multiple sclerosis. J Spinal Cord Med. 2002;25(1):40-2. doi: 10.1080/10790268.2002.11753601. PMID: 11939465.
Copy Download .nbib Format: NLM
Advances in the treatment of multiple sclerosis.

The Western journal of medicine

Krupp LB.
PMID: 8993213
West J Med. 1996 Nov;165(5):320-1.

No abstract available.

Cite
Krupp LB. Advances in the treatment of multiple sclerosis. West J Med. 1996;165(5):320-1
Krupp, L. B. (1996). Advances in the treatment of multiple sclerosis. The Western journal of medicine, 165(5), 320-1.
Krupp, L B. "Advances in the treatment of multiple sclerosis." The Western journal of medicine vol. 165,5 (1996): 320-1.
Krupp LB. Advances in the treatment of multiple sclerosis. West J Med. 1996 Nov;165(5):320-1. PMID: 8993213; PMCID: PMC1303860.
Copy Download .nbib Format: NLM
Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation.

Behavioural neurology

Messinis L, Papathanasopoulos P, Kosmidis MH, Nasios G, Kambanaros M.
PMID: 29576817
Behav Neurol. 2018 Feb 27;2018:4831647. doi: 10.1155/2018/4831647. eCollection 2018.

No abstract available.

Cite
Messinis L, Papathanasopoulos P, Kosmidis MH, et al. Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation. Behav Neurol. 2018;2018:4831647doi: 10.1155/2018/4831647.
Messinis, L., Papathanasopoulos, P., Kosmidis, M. H., Nasios, G., & Kambanaros, M. (2018). Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation. Behavioural neurology, 20184831647. https://doi.org/10.1155/2018/4831647
Messinis, Lambros, et al. "Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation." Behavioural neurology vol. 2018 (2018): 4831647. doi: https://doi.org/10.1155/2018/4831647
Messinis L, Papathanasopoulos P, Kosmidis MH, Nasios G, Kambanaros M. Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation. Behav Neurol. 2018 Feb 27;2018:4831647. doi: 10.1155/2018/4831647. eCollection 2018. PMID: 29576817; PMCID: PMC5848101.
Copy Download .nbib Format: NLM
Multiple sclerosis, Part I: background and conventional MRI. Foreword.

Neuroimaging clinics of North America

Mukherji SK.
PMID: 19068400
Neuroimaging Clin N Am. 2008 Nov;18(4):xiii. doi: 10.1016/j.nic.2008.09.006.

No abstract available.

Cite
Mukherji SK. Multiple sclerosis, Part I: background and conventional MRI. Foreword. Neuroimaging Clin N Am. 2008;18(4):xiiidoi: 10.1016/j.nic.2008.09.006.
Mukherji, S. K. (2008). Multiple sclerosis, Part I: background and conventional MRI. Foreword. Neuroimaging clinics of North America, 18(4), xiii. https://doi.org/10.1016/j.nic.2008.09.006
Mukherji, Suresh K. "Multiple sclerosis, Part I: background and conventional MRI. Foreword." Neuroimaging clinics of North America vol. 18,4 (2008): xiii. doi: https://doi.org/10.1016/j.nic.2008.09.006
Mukherji SK. Multiple sclerosis, Part I: background and conventional MRI. Foreword. Neuroimaging Clin N Am. 2008 Nov;18(4):xiii. doi: 10.1016/j.nic.2008.09.006. PMID: 19068400.
Copy Download .nbib Format: NLM
[Meta-analysis on relationship between hyperhomocysteinemia and multiple sclerosis].

Zhonghua yi xue za zhi

Zhu Y, Liu HN, Zhang CD, Liang HY.
PMID: 20137633
Zhonghua Yi Xue Za Zhi. 2009 Nov 24;89(43):3055-7.

OBJECTIVE: To determine the relationship between hyperhomocysteinemia and multiple sclerosis (MS).METHODS: Cochrane, Medline, EMbase, Springerlink, Highwire, CBM, CNKI and some other databases were searched for literatures. Articles were identified using the Medical Subject Heading term "hyperhomocysteinemia, homocysteine, multiple sclerosis"....

Cite
Zhu Y, Liu HN, Zhang CD, et al. [Meta-analysis on relationship between hyperhomocysteinemia and multiple sclerosis]. Zhonghua Yi Xue Za Zhi. 2009;89(43):3055-7
Zhu, Y., Liu, H. N., Zhang, C. D., & Liang, H. Y. (2009). [Meta-analysis on relationship between hyperhomocysteinemia and multiple sclerosis]. Zhonghua yi xue za zhi, 89(43), 3055-7.
Zhu, Ying, et al. "[Meta-analysis on relationship between hyperhomocysteinemia and multiple sclerosis]." Zhonghua yi xue za zhi vol. 89,43 (2009): 3055-7.
Zhu Y, Liu HN, Zhang CD, Liang HY. [Meta-analysis on relationship between hyperhomocysteinemia and multiple sclerosis]. Zhonghua Yi Xue Za Zhi. 2009 Nov 24;89(43):3055-7. Chinese. PMID: 20137633.
Copy Download .nbib Format: NLM
What is new in symptom management?.

International MS journal

Henze T.
PMID: 17509249
Int MS J. 2007 Mar;14(1):22-7.

Many people with MS suffer from severe and disabling symptoms that restrict their social and private lives, and hence affect their quality of life; it is, therefore, essential that any symptoms that they experience are reduced effectively. Symptomatic treatment...

Cite
Henze T. What is new in symptom management?. Int MS J. 2007;14(1):22-7
Henze, T. (2007). What is new in symptom management?. International MS journal, 14(1), 22-7.
Henze, T. "What is new in symptom management?." International MS journal vol. 14,1 (2007): 22-7.
Henze T. What is new in symptom management?. Int MS J. 2007 Mar;14(1):22-7. PMID: 17509249.
Copy Download .nbib Format: NLM
Fatigue in multiple sclerosis: a diagnostic and therapeutic challenge.

Expert opinion on pharmacotherapy

Paul F, Veauthier C.
PMID: 22424379
Expert Opin Pharmacother. 2012 Apr;13(6):791-3. doi: 10.1517/14656566.2012.667075. Epub 2012 Mar 19.

No abstract available.

Cite
Paul F, Veauthier C. Fatigue in multiple sclerosis: a diagnostic and therapeutic challenge. Expert Opin Pharmacother. 2012;13(6):791-3doi: 10.1517/14656566.2012.667075.
Paul, F., & Veauthier, C. (2012). Fatigue in multiple sclerosis: a diagnostic and therapeutic challenge. Expert opinion on pharmacotherapy, 13(6), 791-3. https://doi.org/10.1517/14656566.2012.667075
Paul, Friedemann, and Veauthier, Christian. "Fatigue in multiple sclerosis: a diagnostic and therapeutic challenge." Expert opinion on pharmacotherapy vol. 13,6 (2012): 791-3. doi: https://doi.org/10.1517/14656566.2012.667075
Paul F, Veauthier C. Fatigue in multiple sclerosis: a diagnostic and therapeutic challenge. Expert Opin Pharmacother. 2012 Apr;13(6):791-3. doi: 10.1517/14656566.2012.667075. Epub 2012 Mar 19. PMID: 22424379.
Copy Download .nbib Format: NLM
Is epilepsy a real problem in multiple sclerosis patients?.

Epilepsy research

Striano P, Striano S.
PMID: 19540090
Epilepsy Res. 2009 Oct;86(2):237-8. doi: 10.1016/j.eplepsyres.2009.05.012. Epub 2009 Jun 18.

No abstract available.

Cite
Striano P, Striano S. Is epilepsy a real problem in multiple sclerosis patients?. Epilepsy Res. 2009;86(2):237-8doi: 10.1016/j.eplepsyres.2009.05.012.
Striano, P., & Striano, S. (2009). Is epilepsy a real problem in multiple sclerosis patients?. Epilepsy research, 86(2), 237-8. https://doi.org/10.1016/j.eplepsyres.2009.05.012
Striano, Pasquale, and Striano, Salvatore. "Is epilepsy a real problem in multiple sclerosis patients?." Epilepsy research vol. 86,2 (2009): 237-8. doi: https://doi.org/10.1016/j.eplepsyres.2009.05.012
Striano P, Striano S. Is epilepsy a real problem in multiple sclerosis patients?. Epilepsy Res. 2009 Oct;86(2):237-8. doi: 10.1016/j.eplepsyres.2009.05.012. Epub 2009 Jun 18. PMID: 19540090.
Copy Download .nbib Format: NLM
What's in a name? That which we call .

Multiple sclerosis (Houndmills, Basingstoke, England)

Hubbard AL, Golla H, Lausberg H.
PMID: 32672087
Mult Scler. 2021 Jun;27(7):983-988. doi: 10.1177/1352458520941481. Epub 2020 Jul 16.

Very limited progress has been made to date in the treatment of debilitating Multiple Sclerosis (MS) daily onset symptoms. These daily symptoms include motor, sensory, and cognitive impairments as well as an overwhelming feeling of tiredness, often referred to...

Cite
Hubbard AL, Golla H, Lausberg H. What's in a name? That which we call . Mult Scler. 2020;27(7):983-988doi: 10.1177/1352458520941481.
Hubbard, A. L., Golla, H., & Lausberg, H. (2021). What's in a name? That which we call . Multiple sclerosis (Houndmills, Basingstoke, England), 27(7), 983-988. https://doi.org/10.1177/1352458520941481
Hubbard, Amy Lynn, et al. "What's in a name? That which we call ." Multiple sclerosis (Houndmills, Basingstoke, England) vol. 27,7 (2021): 983-988. doi: https://doi.org/10.1177/1352458520941481
Hubbard AL, Golla H, Lausberg H. What's in a name? That which we call . Mult Scler. 2021 Jun;27(7):983-988. doi: 10.1177/1352458520941481. Epub 2020 Jul 16. PMID: 32672087; PMCID: PMC8142120.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 50 entries